CHEMINFORMATICS.ORG
Today's Pharma Headlines: US DOD to commence new trial with Pluristem's PLX-R18 cell therapy against ARS - Atreca raises $35m to advance novel cancer immunotherapies - Pfizer gets FDA nod for blood cancer treatment Besponsa - ...